Literature DB >> 18507934

Conflict and emerging infectious diseases.

Louise A Kelly-Hope.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18507934      PMCID: PMC2600301          DOI: 10.3201/eid1406.080027

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.

To the Editor

In the November 2007 issue of Emerging Infectious Diseases, Gayer et al. () describe how conflict leaves populations in dire poverty, internally displaced or seeking asylum, having poor access to essential services, and consequentially vulnerable to infectious diseases. Cholera, caused by the bacterium Vibrio cholerae, is a disease that seems particularly sensitive to conflict and deserves more consideration. Major risk factors for cholera—poverty, overcrowding, poor hygiene, contaminated food, and lack of safe drinking water (,)—largely resemble the consequences of war and civil fighting. Yet little is known about the relationship between cholera and conflict. This lack of information may be because cholera tends to be epidemic, affecting hundreds to thousands of people across vast, war-torn regions, making it impossible for local governments, nongovernment organizations, and aid workers to control, let alone collect and analyze data. Examination of data sources listed by Gayer et al. () and recent reviews (,) indicate that cholera occurs 1) in countries during war and civil unrest, as exemplified by the latest outbreaks among displaced populations across northern Iraq; 2) in neighboring countries, where temporary camps accommodate masses of political refugees under poor conditions, such as those in eastern Chad near Darfur, Sudan; and 3) during the postwar period when large numbers of repatriated persons return home and consequently place undue pressure on an eroded and fragile national infrastructure, as evident in Angola in recent years. Moreover, all the countries affected by conflict shown in the Appendix Figure by Gayer et al. () have reported cholera outbreaks (–). They are also among the poorest countries in the world; the latest statistics on human development () indicate that compared with all developing countries, on average they have higher rates of undernourishment, refugees, child deaths, and less adequate water and sanitation facilities. Thus, more information is needed about conflict and cholera, especially in Africa.

Appendix Figure

Geographic distribution of recent emerging or reemerging infectious disease outbreaks and countries affected by conflict, 1990–2006. Countries in yellow were affected by conflict during this period (source: Office for the Coordination of Humanitarian Affairs, World Health Organization, www.reliefweb.int/ocha_ol/onlinehp.html). Symbols indicate outbreaks of emerging or reemerging infectious diseases during this period (source: Epidemic and Pandemic Alert and Response, World Health Organization, www.who.int/csr/en). Circles indicate diseases of viral origin, stars indicate diseases of bacterial origin, and triangles indicate diseases of parasitic origin. CCHF, Crimean-Congo hemorrhagic fever; SARS-CoV, severe acute respiratory syndrome coronavirus We agree with Kelly-Hope on the propensity for cholera outbreaks to occur in conflict-affected countries and the need to monitor and respond more effectively to such events. In 2006, cholera was reported from 33 countries in Africa, and 88% of all reported cases were from conflict-affected countries (). As highlighted in our November 2007 article on conflict and emerging infectious diseases (), conflict situations present a multitude of risk factors that enhance disease emergence and transmission, over and above those in other resource-poor countries. Many such conflicts facilitate the occurrence of cholera outbreaks. More precise research on cholera and conflict is indeed necessary. However, despite cholera being a disease that has been around for a long time and that causes frequent outbreaks to this day, much information about this disease, beyond its relationship with conflict, remains unknown. For example, although Vibrio cholerae persists in the environment, little is known about the exact conditions that trigger a cholera outbreak at a particular time. Further elucidation is needed about the factors that influence the duration of an outbreak, disease severity, and duration of individual protective immunity after an episode of cholera. Cholera, which is closely linked to a country’s social and economic development (,), ceased to be of concern in Europe, for example, when access to potable water and sanitation improved although its cause was still unknown and antimicrobial drugs were not yet available. Today, renewed interest from the international public health community is urgently warranted, and strong initiatives are needed to help developing countries (conflict-affected or not) fight against cholera and control this easily preventable disease on a global level.
  4 in total

Review 1.  Review of reported cholera outbreaks worldwide, 1995-2005.

Authors:  David C Griffith; Louise A Kelly-Hope; Mark A Miller
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

2.  Cholera, 2006.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-08-03

3.  Cholera: a new homeland in Africa?

Authors:  Nicholas H Gaffga; Robert V Tauxe; Eric D Mintz
Journal:  Am J Trop Med Hyg       Date:  2007-10       Impact factor: 2.345

Review 4.  Conflict and emerging infectious diseases.

Authors:  Michelle Gayer; Dominique Legros; Pierre Formenty; Maire A Connolly
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

  4 in total
  2 in total

1.  Cholera knowledge, socioeconomic and WaSH characteristics in Aden - Yemen, 2017: a community-based comparative survey.

Authors:  Khaled Al-Sakkaf; Awsan Bahattab; Huda Basaleem
Journal:  J Prev Med Hyg       Date:  2020-10-06

2.  Modalities and preferred routes of geographic spread of cholera from endemic areas in eastern Democratic Republic of the Congo.

Authors:  Harry César Ntumba Kayembe; Didier Bompangue; Catherine Linard; Jérémie Muwonga; Michel Moutschen; Hippolyte Situakibanza; Pierre Ozer
Journal:  PLoS One       Date:  2022-02-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.